Antonino Moschella
Bianchi, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing.
Journal: European journal of human genetics : EJHG
Published: May 13, 2026
Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing.
Journal: European journal of human genetics : EJHG
Published: December 04, 2025
Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing.
Journal: European journal of human genetics : EJHG
Published: December 04, 2025
Large, recursive membrane platforms are associated to Trop-1, Trop-2, and protein kinase signaling for cell growth.
Journal: Molecular biology of the cell
Published: January 09, 2025
Pharmacogenetic Information on Drug Labels of the Italian Agency of Medicines (AIFA): Actionability and Comparison Across Other Regulatory Agencies.
Journal: Clinical and translational science
Published: October 21, 2024
Pharmacogenetics in Italy: current landscape and future prospects.
Journal: Human genomics
Published: February 24, 2024
Phylogenetic conservation of Trop-2 across species-rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks.
Journal: Frontiers in genetics
Published: September 19, 2023
A deterministic code for transcription factor-DNA recognition through computation of binding interfaces.
Journal: NAR genomics and bioinformatics
Published: September 02, 2021
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.
Journal: Neoplasia (New York, N.Y.)
Published: June 30, 2021
Last Updated: 09/26/2026